PM
ACIU icon

Prosight Management’s AC Immune ACIU Stock Holding History

Prosight Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-8,942
Closed -$46K – 38
2020
Q4 		$46K Sell
8,942
-914,175
-99% -$4.66M 0.02% 41
2020
Q3 		$4.5M Sell
923,117
-253,684
-22% -$1.82M 2.14% 19
2020
Q2 		$7.92M Buy
1,176,801
+118,104
+11% +$858K 3.4% 9
2020
Q1 		$7.32M Sell
1,058,697
-184,146
-15% -$1.44M 3.42% 13
2019
Q4 		$10.6M Sell
1,242,843
-5,610
-0.4% -$37.4K 4.65% 8
2019
Q3 		$6.18M Buy
1,248,453
+684,553
+121% +$3.67M 3.43% 11
2019
Q2 		$3.13M Sell
563,900
-146,641
-21% -$747K 1.58% 20
2019
Q1 		$3.59M Buy
+710,541
New +$4.52M 1.57% 26

Other funds holding ACIU

BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Compagnie Lombard Odier SCmA
Compagnie Lombard Odier SCmA 1204 Geneva, Switzerland $9.25B AUM 27.04% 1-Year Est. Return

Prosight Management's ACIU Position: Q1 2021 in Review

Prosight Management sold out of AC Immune (ACIU) in Q1 2021, closing a stake of 8,942 shares — an estimated $46K sold.

Prosight Management first reported a position in ACIU in Q1 2019 and held it in 8 quarters. The position peaked at $10.6M in Q4 2019. 51 funds tracked by Wall St. Rank hold ACIU as of Q1 2021.

  • Prosight Management reported no remaining AC Immune position as of Q1 2021 after selling out during the quarter.
  • Prosight Management sold 8,942 AC Immune shares in Q1 2021, an estimated $46K.
  • Prosight Management first reported a position in AC Immune in Q1 2019 and held it in 8 quarters.
  • Prosight Management's AC Immune position peaked at $10.6M in Q4 2019.
  • 51 funds tracked by Wall St. Rank held AC Immune as of Q1 2021.

Based on Prosight Management's 13F filing for Q1 2021, filed 14 May 2021.